Deborah Borst, Abstract Co-Author: Nothing to Disclose

Kaiyan Kang, Abstract Co-Author: Nothing to Disclose

Rhoda Reading BS, BA, Abstract Co-Author: Nothing to Disclose

Ott Le MD, Abstract Co-Author: Research support, Lantheus Medical Imaging, Inc

Shiva Gupta MD, Abstract Co-Author: Nothing to Disclose

Khaled M. Elsayes MD, Presenter: Nothing to Disclose

Deepak G. Bedi MBBCh, Abstract Co-Author: Consultant, Koninklijke Philips NV

- To discuss various rare testicular neoplasms. - To describe the diagnostic workup and imaging features of these neoplasms. - To correlate imaging features with pathological findings and explain the impact of these manifestations on management.    

- Introduction. - Pathological Classification of rare testicular neoplasms. - Epidemiology. - Laboratory evidences and correlation. - Imaging Manifestations of these rare neoplasms - Impact of imaging manifestations on management.   SUMMARY Various rare benign and malignant neoplasms can involve the scrotum and its contents. Examples of these malignancies include Neurofibromatosis, Lymphoma/Leukemia, Teratoma, mixed non-seminomatous germ cell tumor, Metastatic Prostatic Adenocarcinoma, Plasmacytoma, spermatic cord liposarcoma and spermatic cord myeloma. Although rare, radiologist’s familiarity with imaging and clinical features helps in guiding proper management.  

http://abstract.rsna.org/uploads/2014/14015675/14015675_jbox.pdf

Borst, D, Kang, K, Reading, R, Le, O, Gupta, S, Elsayes, K, Bedi, D, Rare Scrotal Neoplasms; Imaging Features and Pathological Correlation with Impact on Management in the Era of Targeted Therapy  .  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14015675.html